183 related articles for article (PubMed ID: 3161808)
1. Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system.
Hitomi Y; Ikari N; Fujii S
Haemostasis; 1985; 15(3):164-8. PubMed ID: 3161808
[TBL] [Abstract][Full Text] [Related]
2. Plant inhibitors of serine proteinases: Hageman factor fragment, kallikreins, plasmin, thrombin, factor Xa, trypsin, and chymotrypsin.
Hojima Y; Pierce JV; Pisano JJ
Thromb Res; 1980 Oct; 20(2):163-71. PubMed ID: 6451948
[No Abstract] [Full Text] [Related]
3. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.
Fujii S; Hitomi Y
Biochim Biophys Acta; 1981 Oct; 661(2):342-5. PubMed ID: 6271224
[TBL] [Abstract][Full Text] [Related]
4. [The effects of FUT-175 (nafamostat mesilate) on blood coagulation and experimental disseminated intravascular coagulation (DIC)].
Koshiyama Y; Kobori A; Ogihara M; Yokomoto Y; Ohtani K; Shimamura K; Iwaki M
Nihon Yakurigaku Zasshi; 1987 Dec; 90(6):313-20. PubMed ID: 3443413
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.
Aoyama T; Ino Y; Ozeki M; Oda M; Sato T; Koshiyama Y; Suzuki S; Fujita M
Jpn J Pharmacol; 1984 Jul; 35(3):203-27. PubMed ID: 6482087
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases.
Scott CF; Wenzel HR; Tschesche HR; Colman RW
Blood; 1987 May; 69(5):1431-6. PubMed ID: 2436687
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effects of sepimostat mesilate (FUT-187) on the activities of trypsin-like serine proteases in vitro].
Nakamura K; Johmura A; Oda M; Ino Y; Uchiyama H; Ohtani H; Miyazaki H; Kurumi M; Akizawa Y; Oka T
Yakugaku Zasshi; 1995 Mar; 115(3):201-12. PubMed ID: 7738778
[TBL] [Abstract][Full Text] [Related]
8. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
Tans G; Janssen-Claessen T; Rosing J; Griffin JH
Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proteases in coagulation, kinin-forming and complement systems by alpha2-plasmin inhibitor.
Moroi M; Aoki N
J Biochem; 1977 Oct; 82(4):969-72. PubMed ID: 144728
[TBL] [Abstract][Full Text] [Related]
10. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
[TBL] [Abstract][Full Text] [Related]
11. FOY: [ethyl P-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. I. Inhibition of thrombin and factor Xa in vitro.
Ohno H; Kosaki G; Kambayashi J; Imaoka S; Hirata F
Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):579-88. PubMed ID: 6449757
[No Abstract] [Full Text] [Related]
12. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase.
Tamura Y; Hirado M; Okamura K; Minato Y; Fujii S
Biochim Biophys Acta; 1977 Oct; 484(2):417-22. PubMed ID: 143965
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity study of protease inhibitors. V. Chemical modification of 6-amidino-2-naphthyl 4-guanidinobenzoate.
Nakayama T; Taira S; Ikeda M; Ashizawa H; Oda M; Arakawa K; Fujii S
Chem Pharm Bull (Tokyo); 1993 Jan; 41(1):117-25. PubMed ID: 8448813
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics studies of nafamostat mesilate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporeal circulation].
Tsukagoshi S
Gan To Kagaku Ryoho; 2000 May; 27(5):767-74. PubMed ID: 10832450
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of omega-guanidino acid esters on trypsin, plasmin, thrombin and plasma kallikrein.
Muramatu M; Fujii S
J Biochem; 1968 Dec; 64(6):807-14. PubMed ID: 4238018
[No Abstract] [Full Text] [Related]
16. Effect of sepimostat mesilate on experimental venous thrombosis in rats.
Tsuruda A; Kanno S; Ohtani H; Suzuki R; Nishioka M; Koshiyama Y; Kurumi M
Thromb Res; 2001 Feb; 101(3):193-201. PubMed ID: 11228342
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological studies on 6-amidino-2-naphthyl[4-(4,5-dihydro-1H-imidazol-2-yl)amino] benzoate dimethane sulfonate (FUT-187). I: Inhibitory activities on various kinds of enzymes in vitro and anticomplement activity in vivo.
Oda M; Ino Y; Nakamura K; Kuramoto S; Shimamura K; Iwaki M; Fujii S
Jpn J Pharmacol; 1990 Jan; 52(1):23-34. PubMed ID: 1689782
[TBL] [Abstract][Full Text] [Related]
18. Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.
Schapira M; Ramus MA; Jallat S; Carvallo D; Courtney M
J Clin Invest; 1986 Feb; 77(2):635-7. PubMed ID: 3484756
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant activities of heparin and fragments.
Barrowcliffe TW; Thomas DP
Ann N Y Acad Sci; 1989; 556():132-45. PubMed ID: 2660683
[No Abstract] [Full Text] [Related]
20. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
